pp. 4077-4087
S&M3785 Research Paper of Special Issue https://doi.org/10.18494/SAM4738 Published: September 30, 2024 Fundamental Characteristics of Molecularly Imprinted Polymer Nanoparticles with High Affinity for Human Serum Albumin [PDF] Youyuan Man, Shoichi Nishitani, and Toshiya Sakata (Received October 30, 2023; Accepted April 15, 2024) Keywords: Molecularly imprinted polymer nanoparticles, human serum albumin, solid-phase imprinting
In this research, the meticulous development and exhaustive analysis of molecularly imprinted polymer nanoparticles (nano-MIPs) are explored, with particular emphasis on their affinity for human serum albumin (HSA), a crucial biomarker for diagnosing type 2 diabetes mellitus. The yield of the synthesized nano-MIPs for HSA was determined by a freeze drying technique to be in the range of 6–15 mg for every 100 g of glass beads. A multifaceted characterization approach, including dynamic light scattering analysis, atomic force microscopy, and Fourier-transform infrared spectroscopy, was employed to rigorously assess the physicochemical properties of the nano-MIPs. The results indicate a relatively uniform size distribution and a well-defined chemical composition. Surface plasmon resonance kinetic analysis further revealed that the nano-MIPs exhibit high affinity and specificity for HSA, with a dissociation constant (Kd) of 2.37 × 10−9 M and an R2 value of 0.97. These findings not only validate the successful synthesis and characterization of nano-MIPs but also underscore their potential use for selective molecular recognition, thereby providing promising avenues for future research and applications in biomedical and environmental fields.
Corresponding author: Toshiya SakataThis work is licensed under a Creative Commons Attribution 4.0 International License. Cite this article Youyuan Man, Shoichi Nishitani, and Toshiya Sakata, Fundamental Characteristics of Molecularly Imprinted Polymer Nanoparticles with High Affinity for Human Serum Albumin, Sens. Mater., Vol. 36, No. 9, 2024, p. 4077-4087. |